Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,986,000 | 4,509,000 | 4,897,000 | 4,614,000 | 4,590,000 |
| Marketable Securities | 85,000 | 88,000 | 89,000 | 85,000 | 83,000 |
| Inventories | 5,743,000 | 5,417,000 | 5,102,000 | 5,373,000 | 5,494,000 |
| Other current assets | 6,612,000 | 6,773,000 | 6,288,000 | 7,540,000 | 6,713,000 |
| TOTAL | $16,426,000 | $16,787,000 | $16,711,000 | $17,612,000 | $16,880,000 |
| Non-Current Assets | |||||
| PPE Net | 10,662,000 | 10,812,000 | 10,808,000 | 10,971,000 | 10,539,000 |
| Intangibles | 24,329,000 | 24,713,000 | 24,741,000 | 24,336,000 | 24,064,000 |
| Other Non-Current Assets | 6,816,000 | 6,923,000 | 6,821,000 | 5,868,000 | 6,144,000 |
| TOTAL | $41,807,000 | $42,448,000 | $42,370,000 | $41,175,000 | $40,747,000 |
| Total Assets | $58,233,000 | $59,235,000 | $59,081,000 | $58,787,000 | $57,627,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 4,106,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 19,580,000 | 12,033,000 | 3,596,000 | 11,714,000 | 10,880,000 |
| Other current liabilities | 855,000 | 595,000 | 561,000 | N/A | N/A |
| TOTAL | $28,788,000 | $18,757,000 | $19,001,000 | $18,137,000 | $18,107,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 14,620,000 | N/A | N/A |
| Other Non-Current Liabilities | 19,437,000 | 29,041,000 | 14,683,000 | 31,037,000 | 29,932,000 |
| TOTAL | $25,021,000 | $34,885,000 | $35,117,000 | $36,652,000 | $35,294,000 |
| Total Liabilities | $53,809,000 | $53,642,000 | $54,118,000 | $54,789,000 | $53,401,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,343,000 | 1,343,000 | 1,342,000 | 1,341,000 | 1,341,000 |
| Retained earnings | -5,854,000 | -4,906,000 | -5,392,000 | -6,550,000 | -6,081,000 |
| Other shareholders' equity | 2,314,000 | 2,282,000 | 2,220,000 | 2,442,000 | 2,457,000 |
| TOTAL | $811,000 | $1,714,000 | $1,124,000 | $138,000 | $574,000 |
| Total Liabilities And Equity | $54,620,000 | $55,356,000 | $55,242,000 | $54,927,000 | $53,975,000 |